Conflict Issues in a 21st Century Life Sciences Practice: Ethics

MBHB Partner Dr. Kevin Noonan is the featured presenter at this Association of Legal Administrators (“ALA”) sponsored session set for 1:15-2:30 p.m. PT on May 25, 2016 in Los Angeles. The session is being held in conjunction with the 2016 ALA Annual Conference & Exposition.

Conflict Issues in a 21st Century Life Sciences Practice: Ethics 

How are firms and companies handling ethical and business conflict issues in an increasingly specialized world? We will discuss current conflicts and ethics challenges, including the increasingly complicated world of bio-similars and subject-matter conflicts. The discussion will also include best practices for drafting and negotiating an advanced conflict waiver that is enforceable and acceptable to everyone.

Objectives:

• Determine where conflicts can arise and anticipate how to handle them;
  
• Distinguish between ethical conflicts (and their attendant risks) and business conflicts
  
• Identify responsibilities for deciding best litigation strategies for biosimilar applicants and reference product sponsors

Audience: Attendees should have at least three years of experience in the legal industry. No advance preparation is required.

View details here